These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1774268)

  • 21. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
    Cohen D; Green MS; Block C; Rouach T; Ofek I
    J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
    [No Abstract]   [Full Text] [Related]  

  • 24. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.
    Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E
    Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to Escherichia coli and Shigella flexneri in milk from undernourished mothers: studies on sodium dodecyl sulfate-polyacrylamide gel electrophoresis-separated antigens.
    Herías MV; Mattsby-Baltzer I; Cruz JR; Hanson LA
    Pediatr Res; 1997 Nov; 42(5):644-50. PubMed ID: 9357938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
    Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.
    Passwell JH; Ashkenazi S; Banet-Levi Y; Ramon-Saraf R; Farzam N; Lerner-Geva L; Even-Nir H; Yerushalmi B; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Vaccine; 2010 Mar; 28(10):2231-2235. PubMed ID: 20056180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.
    Cohen D; Ashkenazi S; Schneerson R; Farzam N; Bialik A; Meron-Sudai S; Asato V; Goren S; Baran TZ; Muhsen K; Gilbert PB; MacLennan CA
    Clin Microbiol Infect; 2023 Mar; 29(3):366-371. PubMed ID: 36243351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.
    Lin J; Smith MA; Benjamin WH; Kaminski RW; Wenzel H; Nahm MH
    Clin Vaccine Immunol; 2016 Aug; 23(8):681-8. PubMed ID: 27280622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shigella-specific IgA in saliva of children with bacillary dysentery.
    Schultsz C; Qadri F; Hossain SA; Ahmed F; Ciznar I
    FEMS Microbiol Immunol; 1992 Jan; 4(2):65-72. PubMed ID: 1547024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory immunoglobulin A response following peroral priming and challenge with Shigella flexneri lacking the 140-megadalton virulence plasmid.
    Keren DF; McDonald RA; Formal SB
    Infect Immun; 1986 Dec; 54(3):920-3. PubMed ID: 3536753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human milk immunoglobulin A antibodies to Shigella virulence determinants.
    Cleary TG; Winsor DK; Reich D; Ruiz-Palacios G; Calva JJ
    Infect Immun; 1989 Jun; 57(6):1675-9. PubMed ID: 2470676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen.
    Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins.
    Willer Eda M; Lima Rde L; Giugliano LG
    BMC Microbiol; 2004 Apr; 4():18. PubMed ID: 15115555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124.
    Li A; Cam PD; Islam D; Minh NB; Huan PT; Rong ZC; Karlsson K; Lindberg G; Lindberg AA
    J Infect; 1994 Jan; 28(1):11-23. PubMed ID: 8163828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.